Korro Bio, Inc.·4

Mar 12, 8:15 PM ET

Walker Paul Edward 4

Research Summary

AI-generated summary

Updated

Korro Bio (KRRO) 10% Owner Walker Paul Edward Buys 450,045 Shares

What Happened
Walker Paul Edward, reported as a 10% owner, acquired a total of 450,045 Korro Bio (KRRO) securities on March 10, 2026. He purchased 207,100 shares of common stock at $11.11 each (total $2,300,881) and acquired 242,945 pre-funded warrants at $11.11 each (total $2,698,876), for a combined cash outlay of $4,999,757. These were purchases (acquisitions), which are generally viewed as more informative than routine sales.

Key Details

  • Transaction date: March 10, 2026; Form 4 filed March 12, 2026 (timely filing).
  • Prices and amounts:
    • 207,100 common shares @ $11.11 = $2,300,881 (Acquired).
    • 242,945 pre-funded warrants @ $11.11 = $2,698,876 (Acquired; treated as derivative).
    • Total acquired: 450,045 units for $4,999,757.
  • Shares owned after the transaction: not provided in the summary you supplied.
  • Footnotes of note:
    • F1: Securities were acquired from the issuer under a Subscription Agreement dated March 9, 2026.
    • F2: The reporting person is a manager of NEA 17 GP, LLC (structure indicates holdings are through NEA entities and the reporting person disclaims beneficial ownership of portions where he has no pecuniary interest).
    • F3: The pre-funded warrants are exercisable at any time but contain a customary ownership cap — they may not be exercised if doing so would push ownership above 9.99% (holder can adjust this cap to as much as 19.99% with notice).
  • Filing timeliness: Reported on March 12 for a March 10 transaction; this meets the usual two-business-day Form 4 deadline.

Context
Pre-funded warrants are a derivative that lets the holder convert to common shares by paying a nominal additional amount; here they were bought rather than immediately converted, and exercise is subject to the ownership cap noted above. As a reported 10% owner and manager of NEA-related entities, this transaction reflects institutional/strategic buying rather than a routine executive sale. Remain factual: acquisitions can signal confidence but do not prove intent or future performance.